Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

What happened?

Proposal in Congress

  1. Introduced in House

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 This bill reauthorizes through FY2029 the Sickle Cell Disease Treatment…

Read the details

What this means

Status
Proposal in Congress
What happened
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 This bill reauthorizes through FY2029 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve prevention and treatment of sickle cell disease and complications from the disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)
What to check next
The bill was sent to the House Committee on Energy and Commerce for consideration.
Check the original record

Record details

Bill number
H.R. 1796
Congress
119
Introduced
2025-03-03
Sponsor
Rep. James, John [R-MI-10]
Committees
Energy and Commerce Committee
Latest documented action
Referred to the House Committee on Energy and Commerce.

Documented actions

  1. Referred to the House Committee on Energy and Commerce.

  2. Introduced in House

  3. Introduced in House

Sources and related records

Source checked .